tumorigenesis

Notch signaling pathway plays an important role in tumorigenesis in several solid and hematological malignancies.

Non-repairable mtDNA damage constitutes permanent mutations and plays an accelerating role in tumorigenesis. In addition to energy metabolism, mitochondria also control the variability of oxidative stress and regulation of cell death.

Aims: The purpose of this study is to investigate the role of Grail in stress-induced apoptosis and tumorigenesis in oral cancer cells.

According to the company, Chidamide, a benzamide-based, selective inhibitor of class I (subtypes 1, 2, 3) and IIb (subtype 10) HDACs, reverses epigenetic abnormalities related to tumorigenesis. Chidamide induces chromatin remodelling by inhibiting specific subtypes of HDACs which leads to increased acetylation of histones, modifying gene expression in multiple signal transduction pathways.

However, alterations of the canonical Wnt/[beta]-catenin/TCF pathway are implicated in tumorigenesis.

Increasing evidence suggests that there are many unidentified genetic alterations involved in the tumorigenesis of cervical cancer (4).

The association of the WT1 in OSCC and its role in tumorigenesis is not yet established.

The role of TIP30 in tumorigenesis is also evidenced by the reduced expression of TIP30 in human colorectal cancer.[17] The decreased TIP30 expression is associated with poor prognosis in patients with hepatocellular carcinoma.[12] Human hepatocellular carcinoma with methylated TIP30 has shown a tendency toward significantly high recurrence and mortality rates and low DFS.[25] TIP30 can also induce apoptosis and mitochondrial dysfunction, probably through stabilization of p53 mRNA, and this mechanism is blocked by inhibition of p53 expression.[6]

These studies implicate diverse and complex functions of EI24 in tumorigenesis. Our previous microarray analysis showed that EI24 mRNA was upregulated in human PDAC tissues compared with paraneoplastic tissues (2.69-fold increase; P = 0.003) [3].

Cancer genomics has made a great progress to uncover the underlying mechanism of tumorigenesis. Consequently, a lot of cancer genomic biomarkers have been developed for improving cancer diagnosis and prognosis.

Many studies have revealed the molecular mechanisms of the colonic tumorigenesis and have proposed various models such as the adenoma-carcinoma sequence (i.e., multistep carcinogenesis) and colitis-associated carcinogenesis observed in inflammatory bowel diseases (IBD).